In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Nexell Therapeutics initiates program to develop tumour cell test
Baxter to acquire Epic Therapeutics
Nexell and Diaclone expand agreement
Nexell Therapeutics and Diaclone sign licensing agreements
Baxter to acquire manufacturing plant from ML Laboratories
Curative Health Services signs agreement with Baxter for ADVATE distribution
Haemacure receives US$1 million payment from Baxter